Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The EMBO Journal|December 1, 1992
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorL Naldini, L Tamagnone, E Vigna, et al.
The EMBO Journal|October 1, 1991
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorL Naldini, K M Weidner, E Vigna, et al.
Leukemia & Lymphoma|November 8, 2001
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update resultsP L Zinzani, V Stefoni, M Tani, et al.
Spine|March 16, 2005
The indications for interbody fusion cages in the treatment of spondylolisthesis: analysis of 120 casesPaul C McAfee, John G DeVine, Christopher D Chaput, et al.
ESMO Open|July 16, 2025
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patientsE A Martino, G Caridà, D Lofaro, et al.
Oncoimmunology|May 4, 2018
CD44v6 as innovative sarcoma target for CAR-redirected CIK cellsV Leuci, G M Casucci, G Grignani, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
Pageof 3